Calidi Biotherapeutics (CLDI) Institutional Ownership

$1.16

+0.02 (+1.76%)

(As of 09/6/2024 ET)

Current Institutional Ownership Percentage: 12.53%
Number of Institutional Buyers (last 12 months): 7

Number of Institutional Sellers (last 12 months): 0

Get CLDI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Calidi Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CLDI Institutional Buying and Selling by Quarter

Ad Porter & Company

War on Elon Escalates…

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

Calidi Biotherapeutics Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2024	Delta Investment Management LLC	210,230	$42K	0.0%	+1,955.0%	0.413%
8/8/2024	RS Crum Inc.	263,470	$53K	0.0%	+2,327.4%	0.517%
7/19/2024	CPR Investments Inc.	560,000	$112K	0.1%	+700.0%	11.002%
5/16/2024	Apollo Management Holdings L.P.	125,000	$71K	0.0%	N/A	0.352%
5/15/2024	Magnetar Financial LLC	63,132	$36K	0.0%	N/A	0.178%
5/14/2024	Evermay Wealth Management LLC	63,416	$36K	0.0%	N/A	0.178%
4/23/2024	Spectrum Asset Management Inc. NB CA	166,494	$94K	0.0%	N/A	0.468%

(Data available from 1/1/2016 forward)

CLDI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CLDI shares?: During the previous two years, the following institutional investors and hedge funds held shares of Calidi Biotherapeutics shares: CPR Investments Inc. ($112K), Spectrum Asset Management Inc. NB CA ($94K), Apollo Management Holdings L.P. ($71K), RS Crum Inc. ($53K), Delta Investment Management LLC ($42K), and Magnetar Financial LLC ($36K), and Evermay Wealth Management LLC ($36K).Learn more on CLDI's institutional investors.
What percentage of Calidi Biotherapeutics stock is owned by institutional investors?: 12.53% of Calidi Biotherapeutics stock is owned by institutional investors. Learn more on CLDI's institutional investor holdings.
Which institutional investors have been buying Calidi Biotherapeutics stock?: The following institutional investors have purchased Calidi Biotherapeutics stock in the last 24 months: CPR Investments Inc. ($490K), RS Crum Inc. ($252.62K), Delta Investment Management LLC ($200K), Spectrum Asset Management Inc. NB CA ($166.49K), Apollo Management Holdings L.P. ($125K), Evermay Wealth Management LLC ($63.42K), and Magnetar Financial LLC ($63.13K).

How much institutional buying is happening at Calidi Biotherapeutics?: Institutional investors have bought a total of 1,360,658 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions.

Related Companies: